Nutritional therapy in inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 31, Issue 4, 2015, Pages 303-308

  Sarbagili Shabat, Chen ^a   Sigall Boneh, Rotem ^a   Levine, Arie ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Crohn's disease; Diet; Enteral nutrition; Inflammatory bowel disease; Microbiome

Indexed keywords

CARBOHYDRATE; CURCUMIN; STARCH;

ANIMAL MODEL; ARTICLE; CLINICAL TRIAL (TOPIC); DIET; ENTERIC FEEDING; HUMAN; INFLAMMATORY BOWEL DISEASE; NONHUMAN; NUTRITION; NUTRITIONAL THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; INFLAMMATORY BOWEL DISEASES; INTESTINE FLORA; MICROBIOLOGY; PROCEDURES;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; ENTERAL NUTRITION; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84942597785     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000178     Document Type: Article

References (52)

1. Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis 2014;8:1179-1207.
2. Turner D, Levine A, Escher JC, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012;55:340-361.
3. Levine A, Wine E. Effects of enteral nutrition on Crohn disease: clues to the impact of diet on disease pathogenesis. Inflamm Bowel Dis 2013;19:1322-1329.
4. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9:599-608.
5. Jostins L, Ripke S, Weersma R, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.
6. Kaser A, Blumberg RS. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology 2011;140:1738-1747.
7. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521.
8. Rahman K, Sasaki M, Nusrat A, Klapproth JM. Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NFkB signaling. Inflamm Bowel Dis 2014;20:1419-1425.
9. McCole DF. IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis 2014;20:1829-1849.
10. Li Q, Wang C, Tang C, et al. Molecular-phylogenetic characterization of the microbiota in ulcerated and nonulcerated regions in the patients with Crohn's disease. PLoS One 2012;7:e34939.
11. Vogelsang H. Do changes in intestinal permeability predict disease relapse in Crohn's disease? Inflamm Bowel Dis 2008;14:S162-S163.
12. Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012;61:1146-1153.
13. D'Souza S, Levy E, Mack D, et al. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008;14:367-373.
14. Pfeffer Gik T, Levine A. Dietary clues to pathogenesis of Crohn's disease. Dig Dis 2014;32:389-394.
15. Brown K, Decoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012;4:1095-1119.
16. Merga Y, Campbell BJ, Rhodes JM. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Dig Dis 2014;32:475-483.
17. Martinez-Medina M, Denizot J, Dreux N, et al. Western diet induces dysbiosis with increased E. coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014;63:116-124. This is the first study to demonstrate that high-fat, high-sugar diet caused dysbiosis, promoted AIEC gut colonization, and developed increased intestinal permeability and inflammation.
18. Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 2010;7:19.
19. Gruber L, Kisling S, Lichti P, et al. High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity. PLoS One 2013;8:e71661. This study demonstrated that high-fat diet can accelerate ileitis onset in a mouse model by increasing intestinal permeability, alteration of luminal factors and generation of Th17-driven dendritic cells.
20. Wagner SJ, Schmidt A, Effenerger MJ, et al. Semisynthetic diet ameliorates Crohn's disease-like ileitis in TNFDAre/wt mice through antigen-independent mechanisms of gluten. Inflamm Bowel Dis 2013;19:1285-1294. This study demonstrated that gluten-fortified experimental diet induced ileitis in TNFDARE/WT mice.
21. Devkota S, Wang Y, Musch M, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL10-/-mice. Nature 2012;487:104-109.
22. Swidsinski A, Ung V, Sydora B, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis 2009;15:359-364.
23. Roberts C, Keita A, Duncan S, et al. Translocation of Crohn's disease Escherichia coli across M-cells contrasting effects of soluble plant fibres and emulsifier. Gut 2010;59:1331-1339.
24. Lammers K, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008;135:194-204.
25. Tawfik A, Flanagan PK, Campbell BJ. Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2014;20:8751-8763.
26. Nickerson KP, McDonald C. Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One 2012;7:e52132.
27. Dogan B, Suzuki H, Herlekar D, et al. Inflammation-associated adherentinvasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation. Inflamm Bowel Dis 2014;20:1919-1932.
28. Le Leu RK, Young GP, Hu Y, et al. Dietary red meat aggravates dextran sulfate sodium induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci 2013;58:3475-3482.
29. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014;111:2247-2252.
30. Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014;40:128-139.
31. Chan SS, Luben R, Van Schaik F, et al. Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2014;20:2013-2021.
32. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of longterm intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013;145:970-977.
33. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-563. This study in healthy volunteers demonstrated that an animal-based diet has a more significant impact than a plant-based diet on the microbiota. An animal-based diet led to dysbiosis with an increase in sulfide-reducing bacteria such as Bilophila wadsworthia and a decrease in Firmicutes.
34. Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut 2014;0:1-12. These investigators demonstrated that iron fortification led to a significant increase in Enterobacteria and a significant decrease in Firmicutes which is similar in Crohn's disease; as well as an increase in fecal calprotectin levels, an indicator of intestinal inflammation.
35. Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis 2014;20:576-586.
36. James SL, Christophersen CT, Bird AR, et al. Abnormal fibre usage in UC in remission. Gut 2015;64:562-570. This study demonstrated that patients with ulcerative colitis do not metabolize starches to short-chain fatty acids as would be anticipated.
37. Levine A, Turner D, Pfeffer Gik T, et al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group 'growth relapse and outcomes with therapy' (GROWTH CD) study. Inflamm Bowel Dis 2014;20:278-285.
38. Buchanan E, Gaunt WW, Cardigan T, et al. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 2009;30:501-507.
39. Rubio A, Pigneur B, Garnier-Lengline H, et al. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011;33:1332-1339.
40. Johnson T, Macdonald S, Hill S, et al. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula a randomised controlled trial. Gut 2006;55:356-361.
41. Frivolt K, Schwerd T, Werkstetter KJ, et al. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome. Aliment Pharmacol Ther 2014;39:1398-1407.
42. Gerasimidis K, Bertz M, Hanske L, et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis 2014;20:861-871. This study in Crohn's disease patients demonstrated that the mechanism of induction of remission using exclusive enteral nutrition does not induce an improvement in diversity or bacterial metabolism as expected. They found that EEN actually decreased diversity, decreased butyric acid, increased fecal PH and increased fecal sulfide.
43. Sigall-Boneh R, Pfeffer-Gik T, Segal I, et al. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis 2014;20:1353-1360. This is the first study to demonstrate that a diet based on exclusion of animal fat, gluten, emulsifiers and several other hypothetical ingredients that may cause dysbiosis or affect the mucous layer can induce remission in 70% of patients with active Crohn's disease and was associated with mucosal healing.
44. Grover Z, Muir R, Lewindon P. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. J Gastroenterol 2014;49:638-645. This prospective study evaluated mucosal healing by colonoscopy and magnetic resonance enterography after exclusive enteral nutrition and demonstrated 58% good to complete endoscopic mucosa healing and complete transmural healing in 21% of patients.
45. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 2006;24:1333-1340.
46. Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, nonrandomized, parallel, controlled study. Aliment Pharmacol Ther 2007;25:67-72.
47. Yamamoto T, Shiraki M, Nakahigashi M, et al. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis 2013;28:335-340.
48. Hirai F, Ishihara H, Yada S, et al. Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults. Dig Dis Sci 2013;58:1329-1334.
49. Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K. Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease. J Gastroenterol 2010;45:24-29.
50. Kyaw MH, Moshkovska T, Mayberry J. A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life. Eur J Gastroenterol Hepatol 2014;26:910-917.
51. Singla V, Pratap Mouli V, Garg SK, et al. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study. J Crohns Colitis 2014;8:208-214.
52. McLaughlin SD, Culkin A, Cole J, et al. Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis. J Crohns Colitis 2013;7:460-466.